- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (17)
19 result(s) found for: Conscious sedation.
Displaying page 1 of 1.
EudraCT Number: 2014-005170-11 | Sponsor Protocol Number: UCLDexAlf1 | Start Date*: 2015-01-26 |
Sponsor Name:Cliniques universitaires Saint Luc | ||
Full Title: Can we get conscious sedation in optimal safety conditions in an emergency department, by combining dexmedetomidine with alfentanil? | ||
Medical condition: Adult over 18 years, of both sexes, for which a procedural sedation is needed in emergency room. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005443-26 | Sponsor Protocol Number: 9813 | Start Date*: 2006-03-03 |
Sponsor Name:Greater Glasgow Health Board | ||
Full Title: Effect site controlled, reaction time safeguarded, patient maintained sedation with propofol in Healthy Volunteers | ||
Medical condition: IMP will be used to provide conscious sedation for healthy volunteers. No medical condition | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005758-39 | Sponsor Protocol Number: 9812/A | Start Date*: 2006-08-16 |
Sponsor Name:Greater Glasgow Health Board | ||
Full Title: Effect site controlled, reaction time safeguarded, patient maintained sedation with Propofol A) in oral surgery patients B) in general dentistry patients C) in colonoscopy patients | ||
Medical condition: No specific medical condition. IMP will be used to provide conscious sedation for patients undergoing potentially unpleasant procedures including dentistry and colonoscopy. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-004890-26 | Sponsor Protocol Number: R0115 | Start Date*: 2005-01-07 |
Sponsor Name:HULL AND EAST YORKSHIRE NHS TRUST | ||
Full Title: RANDOMISED CONTROLLED TRIAL OF SEDATION FOR COLONOSCOPY-ENTONOX VERSUS MIDAZOLAM/ FENTANYL | ||
Medical condition: COLONOSCOPY | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001567-37 | Sponsor Protocol Number: KUKIDEX-2 | Start Date*: 2016-11-24 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Efficacy of single dose intranasal dexmedetomidine for conscious sedation in dental practice in dentophobic uncooperative patients with intellectual disability. | ||
Medical condition: dentophobia intellectual disability | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002243-17 | Sponsor Protocol Number: DEXCOM | Start Date*: 2014-10-24 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Conscious sedation for procedures in Dental and Minor Maxillofacial Surgery Unit: optimization of the dexmedetomidine dose (Dexdor®). | |||||||||||||
Medical condition: Sedation for procedures in Dental and Minor Maxillofacial Surgery Unit | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003887-48 | Sponsor Protocol Number: R0239 | Start Date*: 2005-12-21 |
Sponsor Name:HULL AND EAST YORKSHIRE NHS TRUST | ||
Full Title: Randomised Controlled Trial of patient-controlled sedation for colonoscopy: Entonox versus target-controlled infusion of propofol | ||
Medical condition: COLONOSCOPY- NO SPECIFIC MEDICAL CONDITION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003749-15 | Sponsor Protocol Number: RES/0186/7211 | Start Date*: 2006-02-02 |
Sponsor Name:Merck, Sharp & Dohme-Clinical Pharmacology,Europe | ||
Full Title: Investigation of the effectiveness of oral lorazepam in managing preoperative dental anxiety in phobic dental patients-A pilot study | ||
Medical condition: Pre operative dental anxiety, in phobic dental patients. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-001496-21 | Sponsor Protocol Number: LOC-2013 | Start Date*: 2013-06-18 |
Sponsor Name:Harry Scheinin | ||
Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness | ||
Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002782-37 | Sponsor Protocol Number: ENT05 | Start Date*: 2005-11-17 |
Sponsor Name:Heart of England NHS Foundation Trust | ||
Full Title: A Randomised Trial of Inhaled Entonox Plus Local Anaesthesia Versus Intravenous Midazolam Plus Local Anaesthesia To Improve Pain Control During Bone Marrow Biopsy | ||
Medical condition: This study will involve a group of patients requiring diagnostic bone marrow aspiration and biopsy. The reasons for these will include haematological abnormalities of the blood count , which may be... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002495-18 | Sponsor Protocol Number: SG2006/1 | Start Date*: 2007-04-08 | |||||||||||
Sponsor Name:Wrightington, Wigan and Leigh NHS Trust | |||||||||||||
Full Title: The use of ketamine in combination with midazolam for the induction of conscious sedation during endoscopic retrograde cholangiopancreatography (ERCP). | |||||||||||||
Medical condition: The study will not investigate any specific disease, but rather the sedation techniques used for endoscopic retrograde cholangiopancreatography, a form of endoscopy which can be used to diagnose an... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003612-30 | Sponsor Protocol Number: 0904HELIOX | Start Date*: 2005-11-23 |
Sponsor Name:Barts and the London NHS Trust | ||
Full Title: A comparison of Helium-oxygen mixture (Heliox) with an oxygen-air mixture in reducing the work of breathing during weaning from mechanical ventilation. | ||
Medical condition: Patients admitted to the intensive care unit who are in the recovery phase of their illness and are weaning from mechanical ventilation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003438-17 | Sponsor Protocol Number: 05/Q1606/143 | Start Date*: 2005-11-07 |
Sponsor Name:Oxford Radcliffe Hospitals NHS Trust | ||
Full Title: SimSepT: Simvastatin and severe sepsis in the ICU | ||
Medical condition: Severe sepsis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004846-28 | Sponsor Protocol Number: NL60118.058.17 | Start Date*: 2018-11-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Efficacy of Sodium Oxybate to promote sleep in the ICU: A randomized controlled trial | ||
Medical condition: Sleep disturbance | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002584-27 | Sponsor Protocol Number: AC-054-301 | Start Date*: 2007-11-07 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | |||||||||||||
Full Title: A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-caus... | |||||||||||||
Medical condition: Indication: Aneurysmal subarachnoid hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) FI (Completed) SE (Completed) DE (Completed) AT (Completed) DK (Completed) ES (Completed) CZ (Completed) IT (Completed) SI (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006785-29 | Sponsor Protocol Number: AC-054-302 | Start Date*: 2009-09-15 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | |||||||||||||
Full Title: A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-caus... | |||||||||||||
Medical condition: Indication: Subarachnoid aneurysmal hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) DK (Prematurely Ended) FI (Prematurely Ended) AT (Prematurely Ended) BE (Completed) CZ (Completed) FR (Completed) DE (Completed) SI (Prematurely Ended) ES (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004469-28 | Sponsor Protocol Number: MR311-4501 | Start Date*: 2018-03-01 | |||||||||||
Sponsor Name:MUNDIPHARMA | |||||||||||||
Full Title: Multicentre, randomised, double-blind study assessing the efficacy and safety of Penthrox® combined with a standard analgesia (SoC) in comparison to a placebo combined with a standard analgesia (So... | |||||||||||||
Medical condition: Emergency relief of moderate to severe pain associated with trauma in conscious adult patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004355-37 | Sponsor Protocol Number: B5301001 | Start Date*: 2013-06-04 |
Sponsor Name:Pfizer Inc. | ||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, WITHIN-SUBJECT, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06473871 IN REDUCING HYPERTROPHIC SKIN SCARRING | ||
Medical condition: Hypertrophic skin scarring | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) HU (Completed) ES (Completed) NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002548-15 | Sponsor Protocol Number: VTS301 | Start Date*: 2015-12-01 |
Sponsor Name:Vtesse LLC, a Mallinckrodt Pharmaceutical Company | ||
Full Title: A Phase 2b/3 Prospective, Randomized, Double-blind, Sham-controlled Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects with Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease | ||
Medical condition: Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
